From October 1, 2022 to December 31, 2022, the company has repurchased 540,000 shares, representing 0.1% for CNY 2.7 million. With this, the company has completed the repurchase of 7,198,500 shares, representing 1.28% for CNY 37.65 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.53 CNY | -1.09% | -7.17% | -26.10% |
1st Jan change | Capi. | |
---|---|---|
-26.10% | 353M | |
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.